Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T17:50:39.158Z.
Calculation as of: 2026-10-06T17:50:39.158Z.
Quote observation: 2026-10-06T17:50:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 271c6898cd70d4c389427987313f1838723d439a48fe58857c9b6a6cb9daa9ad
EARNINGS YIELD
N/A
Market Cap
$666.00M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$667.67M
Earnings Yield
0.87%
TTM Avg
4.56%
3Y Avg
4.76%
5Y Avg
4.76%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aura Biosciences, Inc. (AURA) | $634.26M | N/A | N/A | N/A | N/A |
| SOPHiA GENETICS S.A. (SOPH)vs › | $632.15M | N/A | N/A | N/A | N/A |
| OmniAb, Inc. (OABI)vs › | $638.60M | N/A | N/A | N/A | N/A |
| Prime Medicine, Inc. (PRME)vs › | $628.55M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $616.72M | N/A | N/A | N/A | N/A |
| Starling Oncology, Inc. (STLN)vs › | $657.89M | N/A | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $666.00M | N/A | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $664.82M | N/A | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $667.67M | 0.87% | 4.56% | 4.76% | 4.76% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.01M | 21.05% | 9.68% | 7.09% | 13.06% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
